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Vascular smooth muscle cell (VSMC) accumulation is a hallmark of atherosclerosis,1 and VSMCs also generate 
the bulk of the neointima formed after vessel occlusion or inju-
ry.2–4 VSMCs display remarkable phenotypic plasticity in vitro,5 
and lineage-tracing experiments have convincingly shown that 
VSMC phenotypic switching occurs in vivo.3,4,6–9 Healthy, ma-
ture VSMCs are quiescent and express contractile genes, such 
as alpha smooth muscle actin (aSma) and smooth muscle myo-
sin heavy chain (SMMHC/Myh11). These contractile genes are 
downregulated when VSMCs undergo phenotypic switching, 
which result in increased proliferation, migration, and expres-
sion of extracellular matrix.10 Lineage-tracing experiments have 
demonstrated that VSMC-derived cells not only form the aS-
ma-positive cells in the fibrous cap, which protects from plaque 
rupture, but also contribute substantially to the generation of the 
plaque core. Specifically, mouse models of atherosclerosis man-
ifest VSMC-derived cells that lack aSma and the mature VSMC 
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contrast, VSMC-derived cells generating the neointima after vascular injury generally retained the expression of 
VSMC markers and the upregulation of Mac3 was less pronounced. Monochromatic regions in atherosclerotic 
plaques and injury-induced neointima did not contain VSMC-derived cells expressing a different fluorescent 
reporter protein, suggesting that proliferation-independent VSMC migration does not make a major contribution 
to VSMC accumulation in vascular disease.
Conclusions: We demonstrate that extensive proliferation of a low proportion of highly plastic VSMCs results 
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marker SMMHC/Myh11 but instead express genes associated 
with other cell types, including macrophages (Mac3),6–9 which 
may contribute negatively to disease progression. Importantly, 
this transdifferentiation is also observed in human plaques,6,8 
highlighting the importance of VSMC plasticity in disease.
VSMC migration has also been proposed to play a major 
contribution to the accumulation of VSMCs in disease, with 
suggestions that up to 50% of neointimal cells result from mi-
gration of nondividing cells after vascular injury.11,12 Despite 
extensive investigation of regulators of VSMC phenotypic 
switching, the proliferation, migration, and plasticity of indi-
vidual VSMCs in vascular disease, however, remain controver-
sial. In particular, it is unknown whether all, or only a fraction, 
of VSMCs in major arteries proliferate and display plasticity 
and whether individual cells can switch to multiple phenotypes 
or whether these arise from different VSMC subsets.
Here, we report that clonal expansion of a low proportion of 
mature VSMCs underlies VSMC accumulation after vascular 
injury and demonstrate that individual VSMCs have the ability 
to generate plaque cells of different phenotypes. Furthermore, 
we find that VSMCs within the media underlying atheroscle-
rotic plaques display features of phenotypic switching without 
contributing to cells within the plaque. Importantly, our data 
strongly suggest that migration of nonproliferating cells makes 
a minor contribution to VSMC accumulation in disease.
Methods
Detailed descriptions of experimental procedures and animals used 
are provided in the Online Data Supplement.
All animal experiments were approved by the UK Home Office 
(PPL70/7565) and the local ethics committee and were performed 
according to the UK Home Office guidelines. The Myh11-CreERt2,13 
Rosa26-Confetti,14 and ApoE−/−15 lines have all been described. For 
atherosclerosis studies, Myh11-CreERt2/Rosa26-Confetti/ApoE−/− 
animals were injected with tamoxifen at 6 to 8 weeks and were fed 
a high-fat diet from week 9 until analysis, as described in Online 
Data Supplement. Tissue was sectioned, immunostained, and cleared 
before the confocal microscopy analysis as described in the Online 
Data Supplement. Animals (Myh11-CreERt2/Rosa26-Confetti) un-
dergoing carotid ligation surgery were injected with tamoxifen at 6 
to 8 weeks, the left common carotid artery ligated at the bifurcation 1 
week after the final tamoxifen injection, and allowed to recover for 28 
days post surgery. Whole-mounted tissue was cleared and analyzed 
by confocal microscopy, followed by cryosectioning, immunostain-
ing, and clearing before being reanalyzed by confocal microscopy.
Confocal microscopy Z-stacks were processed using Imaris soft-
ware (Bitplane, Zurich, Switzerland). Images displayed are maximal 
projections of confocal Z-stacks (generated in Imaris) where indicated 
in figure legends or individual scans (generated in FIJI). Quantification 
was performed on confocal Z-stacks in Imaris as described in the Online 
Data Supplement to ensure correct scoring of staining in individual cells.
Results
Multicolor Labeling of VSMCs
To study the proliferation of individual VSMCs in vivo, we 
combined the inducible Myh11-CreERt2 transgene,13 which 
is specifically expressed in mature VSMCs, with the Rosa26-
Confetti multicolor reporter allele (Figure 1A).14 We induced re-
combination in healthy animals with a pulse of tamoxifen, which 
resulted in random labeling of 70% to 95% of VSMCs with 1 of 
4 fluorescent proteins (Online Table I). There was a slight bias 
toward recombination events resulting in expression of red fluo-
rescent protein in 36% of labeled cells, compared with 26% for yel-
low fluorescent protein, 9% for nuclear green fluorescent protein, 
and 29% for membrane-bound cyan fluorescent protein (Online 
Figure I, light gray bars). Importantly, the specific Confetti label 
is stably transferred to all progeny after VSMC proliferation in-
dependent of expression status of the Myh11-CreERt2 transgene 
and will, therefore, remain expressed after phenotypic switch-
ing (Figure 1B). As expected for a tissue with a low proliferative 
index, the stochastic labeling of elongated VSMCs generated a 
mosaic pattern (Figure 1C; Online Figure II), which was constant 
over months in healthy animals. Recombination was specific to 
VSMCs as demonstrated by the lack of labeling of cells in other 
Nonstandard Abbreviations and Acronyms
aSma alpha smooth muscle actin
SMMHC smooth muscle myosin heavy chain
VSMC vascular smooth muscle cell
Figure 1. Efficient and specific multicolor vascular smooth 
muscle cell (VSMC) labeling in Myh11-CreERt2/Rosa26-Confetti 
animals. A, Schematic representation of the Myh11-CreERt2 
transgene and the Rosa26-Confetti reporter allele. B, Schematic 
representation illustrating tamoxifen-induced recombination at the 
Rosa26-Confetti locus, resulting in expression of 1 of 4 fluorescent 
proteins, which are stably propagated independent of Myh11 
expression within progeny. C and D, Carotid artery cross sections 
from high density–labeled (C; 10× 1 mg tamoxifen) or low density–
labeled (D; 1× 0.1 mg tamoxifen) animals; region outlined in (i) is 
magnified in (ii). Signals for fluorescent proteins are shown with (left) 
and without (right) nuclear DAPI (4',6-diamidino-2-phenylindole) 
staining (white). C, VSMCs, indicated by arrows in (ii), are labeled 
with red fluorescent protein (RFP), yellow fluorescent protein 
(YFP), nuclear (n) green fluorescent protein (GFP), or membrane-
associated (m) cyan fluorescent protein (CFP), whereas cells within 
the adventitia and endothelium, indicated by arrow heads, are 
unlabeled. In (D[ii]), arrows point to the few labeled VSMCs, and 
open arrows point to unlabeled VSMCs within the media. Scale 
bars are 100 μm in (i) and 50 μm in (ii).
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tissues, including adventitia (Online Figure II), bone marrow, 
peripheral blood, skeletal muscle, lung, and liver (Online Figure 
III), similar to what was reported in published studies using this 
transgene with other reporter alleles.6,8,9,13
Clonal Expansion of Few VSMCs in Atherosclerotic 
Plaques
To study clonal VSMC proliferation in disease, we crossed 
Myh11-CreERt2/Rosa26-Confetti animals onto an ApoE−/− 
background15 and induced recombination in 6- to 8-week-old 
animals before feeding them an atherosclerosis-inducing high-
fat diet (21% fat and 0.2% cholesterol) for 16 to 19 weeks 
(Figure 2A; Online Table II). Accumulation of VSMC-derived 
cells was assessed by confocal microscopy of arterial cross 
sections. As expected,6,8 cells expressing the Confetti reporter, 
which are derived from Myh11-expressing VSMCs, contrib-
uted to both cap and core regions (Figure 2B and 2C; Online 
Figure IV) and constituted a significant proportion of the to-
tal cell number within atherosclerotic lesions. Interestingly, 
VSMC contribution was similar for the fibrous cap, shoulder, 
and core regions (Figure 2D). On average, 70% of plaque 
cells were label-positive (Confetti+) and hence derived from 
VSMCs, but this ranged from 40% to 90%. Stratification of 
VSMC contribution according to the vascular region (Online 
Figure VA) or individual animals (Figure 2E) did not reveal 
significant differences between regions, suggesting that inter-
plaque variation is not linked to blood lipid level variation or 
reflects differences in hemodynamic or VSMC developmental 
origin.16
In contrast to the mosaic stochastic labeling observed in 
the vascular wall, VSMC-derived cells within plaques were 
found in large monochromatic regions with little intermix-
ing between colors as shown in thick 50- to 100-μm sections 
(Online Figure VI; Online Movie I) or 20-μm cryosections 
(Figure 2B and 2C). Plaques showed substantial variation in 
color pattern (Online Figure VI), but the frequency of individ-
ual colors closely correlated with labeling frequency, demon-
strating that there was no bias toward expansion of particular 
colors (Online Figure I). Quantification of colored regions 
revealed that most plaques contained 1 or 2 colors (52% and 
40%) with a small proportion presenting 3 (6%) or 4 colors 
(2%; Figure 2F). We compared this observed distribution of 
colors per plaque (Figure 2F) to the expected distributions in 
plaques derived from the proliferation of 1, 2, 3, or 4 cells 
(Figure 2G), which were calculated based on the observed re-
combination frequency. The disparity from the expected color 
pattern generated if 3, 4, or more cells proliferate, strongly ar-
gues that, typically, a few mature Myh11-expressing VSMCs 
undergo massive expansion to contribute to plaque formation. 
However, our analysis clearly shows that plaques in athero-
sclerotic animals are not exclusively monoclonal, in agreement 
with recent studies using lineage tracing of SM22a-expressing 
cells,7 but in contrast to X-inactivation–based analysis of hu-
man lesions.17
We confirmed that monochromatic regions arise from 
clonal expansion of a single cell using lower tamoxifen doses 
to achieve reduced labeling frequencies. A 10-fold reduction 
in tamoxifen dose (to 1× 1 mg/animal) resulted in labeling 
40% of VSMCs, which produced many unlabeled plaques 
or plaques, where a single-colored region occupied a large 
part of the plaque area (Online Figure VII). In addition, we 
only observed a single monochromatic region within plaques 
Figure 2. Vascular smooth muscle cell (VSMC)–derived cells 
generate oligoclonal atherosclerotic plaques. A, Experimental 
protocol for the atherosclerosis studies. B and C, Arterial 
cryosections from high density–labeled animals (10× 1 mg 
tamoxifen) presenting plaques containing VSMC-derived cells of 
a single color (membrane-associated cyan fluorescent protein 
[CFP]; B) and >1 color (red fluorescent protein [RFP], membrane-
associated CFP, and yellow fluorescent protein [YFP]; C). The region 
outlined in (i) is magnified in (ii). Scale bars are 150 μm (i) and 50 μm 
(ii). Signals for fluorescent proteins and nuclear DAPI (4',6-diamidino-
2-phenylindole; in ii, white) are shown. D, Box plot showing the 
proportion of the total number of cells (DAPI), which express 
the Confetti reporter (Confetti+) within each plaque region (in 23 
plaques from 6 animals). E, Bar chart showing the proportion of the 
total number of cells (DAPI), which express the Confetti reporter 
(Confetti+) within plaques for 6 individual animals (23 plaques from 
6 animals). Mean across all animals is indicated by the orange bar, 
SD±0.16. F, Bar chart showing the number of colors observed 
per plaque (82 plaques from 16 animals). G, Bar chart showing 
the theoretical distribution of colors per plaque resulting from 
proliferation of 1, 2, 3, or 4 VSMCs labeled at the recombination 
frequency observed in high density–labeled animals. All data are 
from animals labeled at high density (10× 1 mg tamoxifen).
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from 4 animals receiving 0.1 mg tamoxifen (Online Table II). 
Importantly, the size of the monochromatic regions observed 
in animals with reduced labeling frequency was comparable 
to what was found in high density–labeled animals (Online 
Figure VII). On the basis of these observations, we conclude 
that monochromatic regions within lesions are generally the 
progeny of a single cell, signifying that VSMC-derived cells 
in atherosclerotic lesions are typically formed by the clonal 
expansion of few VSMCs.
Generation of Phenotypically Distinct Cells From 
VSMCs
To assess VSMC plasticity and origin of plaque cells with dif-
ferent phenotypes within monochromatic plaque regions, we 
stained sequential cryosections for either the VSMC marker 
aSma or Mac3, which is upregulated as VSMCs adopt a mac-
rophage-like cell type (Figure 3A and 3B). Quantification of 
staining patterns in different plaque regions showed that aSma+ 
cells were abundant in the cap and shoulder regions (82% and 
Figure 3. Progeny of a single vascular smooth muscle cell (VSMC) can adopt multiple phenotypes in disease. A and B, 
Immunostaining for alpha smooth muscle actin (aSma; A) and Mac3 (B) of serial cryosections from high density–labeled animal (10× 1 mg 
tamoxifen) containing RFP-expressing VSMC-derived cells. Signals for fluorescent proteins, nuclear DAPI (4',6-diamidino-2-phenylindole; 
white), aSma (magenta; A), and Mac3 (magenta; B) are shown as indicated on each image. Regions outlined in (i) are magnified in panels 
(ii through v), scale bars are 150 μm. A, Arrows point to RFP+ aSma+ cells, arrow heads point to RFP− aSma− cells. B, Arrows point 
to RFP+ Mac3+ cells, and arrow heads point to RFP− Mac3+ cells. C through E, Box plot showing proportion of cells that express 
the Confetti reporter and stain positive for either aSma or Mac3 (Confetti+ Stain+), relative to all cells expressing the Confetti reporter 
(Confetti+; C), the total number of cells (DAPI; D), or all cells staining positive for aSma or Mac3 markers (Stain+; E). A red star indicates 
a significant difference (P<0.05) determined by a 2-way analysis of variance. Data in (C through E) are from 23 plaques from 6 animals. 
All data are from animals labeled at high density (10× 1 mg tamoxifen). CFP indicates cyan fluorescent protein; GFP, green fluorescent 
protein; RFP, red fluorescent protein; and YFP, yellow fluorescent protein.
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62%, respectively, of cells expressing the Confetti reporter), 
whereas, on average, only 10% of VSMC-derived cells (8% 
of all cells) in the plaque core expressed aSma (Figure 3C 
and 3D). Two different single-color lineage-tracing studies 
reported that 18%6 or 70%9 of aSma-expressing cells were 
VSMC derived, which both lie within the range shown here. 
The variation possibly reflects the differences between plaque 
regions, which was not considered in these studies.6,9 We find 
that almost all (median 100% and mean 97%) aSma+ cells 
are derived from Myh11-expressing cells (Figure 3E). This 
is consistent with the observations that bone marrow–derived 
cells rarely upregulate VSMC markers, including aSma.18 The 
apparent discrepancy with a recent study showing a significant 
contribution of LysM-Cre-expressing cells to aSma+ plaque 
cells9 possibly results from the use of a constitutively active 
recombinase (rather than tamoxifen inducible) in that study, 
which might be induced in VSMC-derived plaque cells.
Mac3+ VSMC-derived cells were located predominantly 
in the core, where they comprised a significant proportion 
(median 50% of VSMC derived/Confetti+, 34% of all cells, 
and 73% of Mac3+ cells; Figure 3C through 3E). However, 
we also observed a variable, but significant number of Mac3-
expressing VSMC-derived/Confetti+ cells in the cap and 
shoulder regions (7% and 22%, respectively). Interplaque 
variation in staining pattern was not explained by either 
vascular region or differences between animals, except for 
1 mouse showing significantly lower VSMC contribution to 
Mac3-expressing cells (Online Figure VB, VC, and VIII). For 
comparison, previous studies observed that phenotypically 
modulated VSMCs generate ≈30% of all plaque cells6 and that 
12% of plaque cells expressing another macrophage marker 
CD689, which is consistent with our findings.
Individual VSMCs Generate Cells Displaying 
Different Phenotypes
Comparison of Confetti reporter expression with staining 
patterns for aSma and Mac3 within sequential cryosections 
revealed that individual clonal monochromatic regions often 
(27/37 regions in 23 plaques) contain both aSma- and Mac3-
expressing cells. This suggests that VSMC-derived plaque 
cells displaying different phenotype were generated from a 
single VSMC, implying that individual VSMCs are highly 
plastic. To test this idea, we scored the position of 127 mono-
chromatic regions in 82 plaques from 16 high density–labeled 
animals with respect to plaque cap and core (Online Table III). 
Some monochromatic regions were restricted to a specific sec-
tor of a lesion (11% for cap and 13% for core; Figure 4A) and 
often (>35%) >1 color was observed within either plaque core 
or cap (Online Figure IXA). However, most monochromatic 
regions (96/127) spanned both plaque domains (Figure 4A). 
Figure 4. Progeny of a single vascular smooth muscle cell (VSMC) generates plaque cells with different phenotypes. A, Bar chart 
showing the proportion of monochromatic regions, which occupy both the cap and core or only a single region within an atherosclerotic 
plaque (82 plaques from 16 high density–labeled animals). B, Arterial cryosection from artery containing red fluorescent protein (RFP)–
expressing VSMC-derived cells, costained for alpha smooth muscle actin (aSma) and Mac3. The region outlined in (i) is magnified in (ii 
through iv). Arrows point to RFP+ Mac3+ aSma+ cells. Scale bars are 150 μm (i) and 50 μm (ii through vi). Signals for fluorescent proteins, 
nuclear DAPI (4',6-diamidino-2-phenylindole; white), aSma (green) and Mac3 (magenta) are shown as indicated on each image. C, Box plot 
showing the proportion of cells expressing the Confetti reporter (Confetti+), which costain for aSma and Mac3 (Confetti+ aSma+ Mac3+) 
within different plaque regions (7 plaques from 6 mice). Only red and blue plaques were used for this analysis as the 488 channel was 
required for aSma imaging. All data are from animals labeled at high density (10× 1 mg tamoxifen). CFP indicates cyan fluorescent protein.
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Importantly, the frequency of such putative bipotent regions 
was significantly larger than expected by independent chance 
labeling of 2 proximate unipotent clones (χ2=228, P<0.01, 3 
degrees of freedom, n=96; statistics analysis for each color in 
Online Data Supplement). In addition, supporting the conclu-
sion that individual VSMCs can give rise to both fibrous cap 
and plaque core cells, monochromatic regions in animals with 
reduced labeling frequency also spanned both cap and core 
regions (14/17 regions from 14 plaques in 5 animals).
Costaining for aSma and Mac3 demonstrated a low, but 
consistent, proportion of lineage-labeled plaque cells that 
express markers of both phenotypes (Figure 4B). Double-
positive cells were most abundant in the core and generally 
located in the region bordering the fibrous cap (Figure 4B 
and 4C). Interestingly, only 3 of >1100 cells scored costained 
for aSma and Mac3 without expressing the Confetti reporter, 
compared with 57 that were positive for aSma, Mac3, and 
the Confetti reporter, suggesting that coexpression of VSMC 
and macrophage markers is specific to VSMC-derived plaque 
cells. Recent single cell analysis similarly suggested coex-
pression of inflammatory and VSMC markers in VSMC-
derived plaque cells, but cell-by-cell data were not presented 
precluding a direct comparison.9 Taken together, this analysis 
demonstrates that individual VSMCs have the ability to gener-
ate plaque cells of different phenotypes.
Plasticity of VSMCs That Do Not Form 
Monochromatic Regions in the Plaque
In advanced lesions, the medial layer directly underlying 
plaques was often thickened with loss of the characteristic 
elongated cell and nucleus morphology of VSMCs (Figure 5A 
and 5B), indicating that phenotypic changes occur in cells that 
do not contribute to plaque development. To test this idea, we 
quantified marker expression in the media underlying plaques 
compared with the media of regions without visible plaque 
within the same tissue section. To ensure that the analysis was 
restricted to nonexpanding cells, we only analyzed medial 
cells expressing Confetti colors different from those pres-
ent within the lesion. Relative to medial VSMCs adjacent to 
the plaque, which were nearly all aSma+ (median 100% and 
mean 99%), there was a significant reduction in aSma staining 
in the media under the plaque (25% to 100%, median 68%), 
suggestive of phenotypic switching of these cells (Figure 5C). 
This confirms previous reports.6 Correspondingly, expression 
of Mac3 was significantly more frequent in Confetti+ cells in 
the media under the plaque (median 32%) compared to adja-
cent media where Mac3-positive cells were rarely observed 
(median 0%; Figure 5C). This demonstrates that changes in 
VSMC phenotype occur independent of cell expansion but 
that these changes in medial cells are likely to be a response to 
the plaque environment and, therefore, a consequence rather 
than a cause of neointimal growth.
Interestingly, there was a modest, but not significant, re-
duction in the frequency of cells expressing the Confetti re-
porter within the media underlying the plaque compared with 
the adjacent media. Furthermore, whereas virtually no Mac3+ 
cells were observed in the adjacent media, a significant pro-
portion of Confetti− Mac3+ cells were found in the media 
underlying plaques, suggesting an influx of Mac3-expressing 
Figure 5. Vascular smooth muscle cells (VSMCs) within the 
media directly underlying atherosclerotic plaques undergo 
phenotypic switching without contributing to the cell mass 
of the lesion. A and B, Serial cryosections from artery of high 
density–labeled (10× 1 mg tamoxifen) animal containing a plaque 
with RFP+ VSMC–derived cells, stained for alpha smooth muscle 
actin (aSma) (A) and Mac3 (B). The region outlined in (i) is magnified 
in (ii through iv), white dotted lines outline the media. Signals for 
fluorescent proteins, nuclear DAPI (4',6-diamidino-2-phenylindole; 
white), aSma (magenta; A), and Mac3 (magenta; B) are shown as 
indicated on each image. Arrows in (A) point to aSma-negative cells 
within the media, which express the Confetti reporter (excluding 
RFP-expressing cells). Arrows in (B) point to Mac3-positive cells 
within the media, which express the Confetti reporter (excluding 
RFP-expressing cells). Scale bars are 150 μm in (i) and 50 μm 
in (ii through vi). C, Box plot quantifying the proportion of cells 
expressing the Confetti reporter, which stain positive for aSma or 
Mac3 (Confetti+ Stain+), relative to all cells expressing Confetti 
fluorescent proteins not found in the plaque (Confetti+, −plaque 
color) within the media underlying or adjacent to a plaque (based 
on 17 plaques from 6 animals). Red stars indicate a significant 
difference based on a 2-way analysis of variance, P<0.05. All data 
are from animals labeled at high density (10× 1 mg tamoxifen). CFP 
indicates cyan fluorescent protein; GFP, green fluorescent protein; 
RFP, red fluorescent protein; and YFP, yellow fluorescent protein.
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cells (eg, from the bone marrow or adventitia), accompanying 
plaque development.
VSMC Proliferation After Vessel Injury
To test whether the low frequency of proliferating VSMCs in 
advanced atherosclerotic lesions is a consequence of a low 
inflammatory signal from the lipid-rich diet or an inherent 
trait of the VSMC population, we labeled Myh11-CreERt2/
Rosa26-Confetti animals at high frequency (10× 1 mg tamoxi-
fen) before ligation of the left carotid artery (Figure 6A), which 
induces robust and rapid VSMC proliferation.19 As expected, 
confocal microscopy analysis of the whole-mounted carotid 
arteries revealed that VSMCs in the control right carotid ar-
tery did not proliferate (Figure 6B). In contrast, the neointima 
formed in the left carotid artery 28 days after surgery was 
composed of large contiguous monochromatic VSMC-derived 
patches, which occupied a defined volume. This observation 
suggests that the neointima is formed by clonal proliferation 
of a small proportion of VSMCs (Figure 6C). Intermingling 
of colors was only observed where ≥2 colored patches meet 
(Figure 6C[iii]). Most animals displayed 2 to 7 colored patch-
es, but this ranged from 1 to 20 (Online Table IV) and cor-
related with the size of the remodeled area (R2=0.7). Similar 
to atherosclerotic plaques, patches of all colors were observed 
after ligation at frequencies comparable to the labeling fre-
quency (Online Figure I), again confirming that recombina-
tion does not confer selective advantage to cells expressing a 
particular fluorescent protein.
Patch size ranged from 48 to >7000 with a median of 435 
cells per patch (Figure 6D; Online Table IV). Importantly, 
Figure 6. A subset of vascular smooth muscle cells (VSMCs) proliferate to form the injury-induced neointima. A, Experimental 
protocol for carotid artery ligation studies. B and C, Whole-mounted control right carotid artery (B) or ligated left carotid artery (C) from a 
high density–labeled animal (10× 1 mg tamoxifen) 28 days post surgery. Maximal projection of confocal Z-stack covering the entire artery 
is shown in (B) and (C[i]), whereas (C[ii] and C[iii]) show magnified longitudinal cross section of the regions outlined in (C[i]). D, Box plot 
showing the size of individual monochromatic patches. The patch sizes of low (blue circles) and medium density–labeled animals (orange 
crosses) largely fall within the interquartile range observed in high density–labeled animals (green crosses), strongly suggesting that 
patches result from clonal expansion of a single cell. Large patches (>1500 cells) might arise from merging of same colored clones. Fifty-
two patches from 12 high density–labeled (10× 1 mg), 15 patches from 4 medium density–labeled (1× 1 mg), and 8 patches from 4 low 
density–labeled animals (1× 0.1 mg) were analyzed. E, Maximal confocal Z-stack projection of whole-mounted ligated left carotid artery 
from a low density–labeled animal (1× 0.1 mg tamoxifen), analyzed 28 days post ligation. Signals for fluorescent proteins are shown. All 
scale bars are 150 μm. CFP indicates cyan fluorescent protein; GFP, green fluorescent protein; RFP, red fluorescent protein; and YFP, 
yellow fluorescent protein.
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the differences in patch size within the same vessel were on 
the same scale as interanimal variation, suggesting that this 
variation is not due to differences associated with the liga-
tion surgery. To assess whether patches resulted from chance 
merging of independent clones of the same color, we gener-
ated low and medium density–labeled animals (≈1% and 40% 
recombination) using reduced tamoxifen doses (1× 0.1 and 
1× 1 mg per animal). Remodeled arteries of animals with re-
duced labeling frequency presented isolated labeled patches 
comparable to those observed in high density–labeled animals 
(Figure 6D and 6E). However, median patch size was lower, 
suggesting that large clones (>1500 cells) could be the result 
of patch merging. These results demonstrate that a subset of 
Myh11-expressing cells undergoes multiple rounds of divi-
sion to generate the neointima after vascular injury. On the 
basis of a VSMC density of ≈5000 cells/mm2,20 carotid artery 
diameter (470 μm),21 and on average 2.7±1.0 patches per mm 
remodeled artery (Online Table IV), we estimated that <0.1% 
of VSMCs contributed to the formation of the neointima 28 
days post ligation. The finding that disease-associated VSMC 
accumulation results from clonal expansion of a restricted 
subset of VSMCs that express the mature SMMHC/Myh11 
marker in 2 different animal models suggests that this is an 
inherent feature of this cell population.
VSMC Plasticity After Vessel Injury
To examine whether clonal proliferation after vascular injury 
was accompanied by similar phenotypic changes to those ob-
served in atherosclerosis, we immunostained cross sections 
of arteries (after whole mount imaging) for aSma and Mac3 
(Figure 7A through 7C). aSma was expressed in most VSMC-
derived neointimal cells 28 days post surgery, although there 
was a reduction compared with healthy arteries (Online Figure 
X). In contrast to atherosclerotic plaques, there was little spe-
cific localization of aSma+ and aSma− cells expressing the 
Confetti reporter, although a degree of clustering of aSma-
negative cells was observed in some samples (data not shown). 
We observed an upregulation of Mac3 in a subset of VSMC-
derived cells (Figure 7C), but the expression level seemed to 
be lower than in Mac3+ Confetti+ cells within plaques (Figure 
3B). These results demonstrate a clear difference in phenotyp-
ic switch–associated gene expression changes between the 2 
disease models. We, therefore, tested whether VSMC-derived 
cells in injury-induced neointima show evidence of an earlier 
stage of phenotypic switching by staining for SMMHC, which 
marks fully mature VSMCs and has been reported to be down-
regulated early during phenotypic switching.10 However, the 
staining pattern for SMMHC was similar to aSma, suggesting 
that VSMCs in the neointima exist in a largely contractile state 
(Online Figure XIA).
Migration of VSMCs in Disease
Interestingly, VSMC-derived neointimal patches were con-
nected to patches expressing the identical Confetti color 
within the medial layer (Online Figure XII). This suggests 
that VSMC proliferation initiates in the media and that VSMC 
progeny then migrate through the elastic laminae, where they 
continue dividing to form the lesion (Online Figure XIB).19 
Occasional medial patches without a linked neointimal patch 
of the same color were observed, indicating that proliferation 
is not strictly correlated with migration, but that these could 
be independent events. However, we did not find evidence for 
significant contribution of migration independent of prolif-
eration to neointima growth, which would generate a mosaic 
neointima similar to the medial labeling pattern. In particular, 
coherent neointimal patches did not contain singlet VSMCs 
expressing other fluorescent proteins (Figure 6C), which 
would be observed if many cells from the randomly labeled 
medial wall migrate. This was substantiated by the absence 
of intermingling of cells expressing different Confetti colors, 
except at border regions between patches (Figure 6C[iii]).
Similarly, we did not find evidence that migration of non-
proliferating cells contributes significantly to atherosclerotic 
plaque development. Most monochromatic regions formed 
a coherent structure and few (<10%) displayed intercalation 
of cells of different colors (for an example of intercalating 
plaque, Online Figure VIB). Monochromatic VSMC-derived 
plaque regions did contain interspersed nonlabeled cells 
(Figure 3A and 3B; arrows heads), which is consistent with 
the known infiltration of monocytes that contribute to lesion 
development. As VSMC labeling was not 100% efficient, we 
cannot rule out that these result from VSMC migration, but 
this is unlikely as we did not observe plaques that contained 
VSMC-derived cells expressing another Confetti color within 
a monochromatic region. We, therefore, suggest that migra-
tion of VSMCs independent of proliferation is a minor contri-
bution to VSMC accumulation in vascular disease.
Discussion
The multicolor lineage–tracing experiments presented here 
show that extensive proliferation of a small subset of mature, 
but plastic, VSMCs within major arteries generates neointi-
mal VSMC-derived cells in 2 different vascular disease mod-
els. Proliferating VSMCs undergo multiple cell divisions to 
form large oligoclonal plaques, potentially explaining the 
replicative exhaustion, telomere shortening, and increased 
senescence observed in human plaques.22,23 Consistent with 
extensive proliferation of VSMC-derived cells, we observed a 
high proportion of EdU (5-ethynyl-2'-deoxyuridine)-positive 
Confetti-expressing cells within the neointima of animals that 
received repeated EdU injections after carotid ligation (Online 
Figure XIB). Our study correlates with and extends findings 
from LacZ-lineage tracing of SM22a-positive cells, which 
marks both mature and immature VSMCs.7 However, our data 
in normal adult mice contrast with findings that multiple ex-
isting cells proliferate to occlude the vessels of elastin-mutant 
embryos.24 This difference is most likely due to lineage la-
beling of less differentiated embryonic cells (E12.5) in that 
study24 compared with adult VSMCs here. The observation 
that a small fraction of Myh11-expressing VSMCs undergoes 
clonal expansion in 2 distinct disease models could suggest 
the existence of specialized cells within arterial walls. This is 
important as treatments that specifically target the prolifera-
tive VSMC population might retain the structural integrity of 
the artery after injury or in atherosclerosis.
Remarkably, most VSMC clones comprise both macro-
phage-like cells in the core and aSma-positive cap cells. This 
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observation establishes that individual VSMCs show pheno-
typic plasticity as opposed to different VSMC subsets giving 
rise to different phenotypes. Interestingly, although advanced 
atherosclerotic plaques have low proliferative indices,25 EdU-
labeled VSMC-derived cells were observed in both cap and core 
regions of established plaques, suggesting that cells displaying 
Figure 7. Injury-induced vascular smooth muscle cell (VSMC)–derived neointima contains few phenotypically switched VSMCs. 
A, Maximal projection of 3 central scans (7 μm apart) of a confocal Z-stack of whole-mounted ligated left carotid artery from high 
density–labeled (10× 1 mg tamoxifen) animal, 28 days post ligation. Scale bar is 300 μm. B and C, Transverse cryosections from the 
region outlined in (A), stained for alpha smooth muscle actin (aSma; B), or Mac3 (C); the region outlined in (i) is magnified in (ii through 
iv). Arrows point to cells expressing the Confetti reporter (Confetti+) that do not stain for aSma (B) and Confetti+ Mac3+ cells (C) within 
the neointima. Arrow heads point to Confetti+ aSma+ cells (B) or Confetti+ Mac3− cells (C) within the neointima. Scale bars are 50 μm. 
Signals for fluorescent proteins, nuclear DAPI (4',6-diamidino-2-phenylindole; white), aSma (magenta, B), and Mac3 (magenta, C) are 
shown as indicated on each image. D, Box plot showing the proportion of all cells (DAPI) within the neointima, which express the Confetti 
reporter (Confetti+). E, Box plot displaying the proportion of Confetti+ neointimal cells that stain positive for aSma or Mac3 (Stain+; based 
on 5 regions from 4 animals). All data are from high density–labeled (10× 1 mg tamoxifen) animals. CFP indicates cyan fluorescent protein; 
GFP, green fluorescent protein; RFP, red fluorescent protein; and YFP, yellow fluorescent protein.
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different phenotypes undergo cell division within the plaque 
(Online Figure XIII). Our observation that VSMC-derived 
cells expressing markers of both phenotypes are found at the 
border between the aSma-postive cap and the core region, con-
taining macrophage-like VSMC-derived cells, (Figure 4B and 
4C) opens the possibility that the VSMC-derived cells could 
interconvert between different phenotypic states depending on 
the environmental cues. This is important as it suggests that 
plaque stabilization could be achieved by therapeutic biasing 
of proliferating VSMCs toward the protective cap phenotype.
We did not observe differences in the frequency of prolif-
erating VSMCs, their ability to contribute to both cap and core 
regions, or their bias toward aSma+ or Mac3+ phenotypes be-
tween plaques located in the descending aorta compared with 
the ascending aorta, aortic arch, and carotid arteries (Online 
Figure IX). This indicates a similar activation frequency and 
plasticity for VSMCs from different vascular regions, suggest-
ing that there are no overt differences in plasticity of VSMCs 
generated from different embryonic origins (mesodermal for 
descending aortic VSMCs versus neural crest for VSMCs 
within aortic arch and carotid arteries16).
Our data suggest that VSMC proliferation and phenotypic 
switch–associated gene expression changes are not linked. For 
example, medial cells directly underlying the plaque downreg-
ulate aSma and express Mac3 without contributing to plaque 
mass, and clonally expanded VSMC-derived cells in the inju-
ry-induced neointima maintain aSma expression. Furthermore, 
we show that migration of VSMCs does not make a major 
contribution to VSMC accumulation in vascular diseases. Our 
study, therefore, adds in vivo single cell evidence supporting a 
notion that different aspects of VSMC phenotypic switching, 
including VSMC migration, contractile marker expression, and 
proliferation, could be regulated independently.
It is not clear why only a small proportion of VSMCs con-
tributed to the observed disease-associated VSMC accumula-
tion, in light of the general response of VSMCs reported after 
vessel injury.26 Interestingly, studies using radiolabeled thymi-
dine to measure cell division in pig and rat models of vascular 
disease suggested that cell proliferation occurs more gener-
ally in the media.27,28 Those studies analyzed animals at ear-
lier time points of disease, as opposed to our analyses of later 
stages. The apparent difference in the fraction of proliferating 
medial cells found in those studies and the restricted number 
of VSMCs we observe contributing to the neointima might, 
therefore, be due to the differences in time of analysis. For 
example, clonal selection or cell competition could occur at 
later time points after a more general response. Alternatively, 
the different phenotypes could arise from differences between 
experimental models or the inability to discriminate between 
VSMCs and infiltrating cells in the previous studies, which 
did not use lineage labels.27,28 In any case, it will be interesting 
to study why the observed phenotypic changes occurring gen-
erally in all VSMCs is reversible in most cells but not in a few 
of the cells. The restriction of migration through the elastic 
laminae to expanding cells might suggest that the expression 
of matrix-remodeling factors could be involved. One possi-
bility is that the differential activation of VSMCs we observe 
is due to the observed heterogeneity between cells in healthy 
vessels.10 Future studies should reveal whether limitation of 
VSMC contribution to disease-associated cell accumulation in 
major arteries to a few mature VSMCs that proliferate exten-
sively is associated with somatic mutation,29 a preselected pro-
genitor pool primed by epigenetic heterogeneity, as suggested 
for neomuscularization of distal pulmonary arterioles,30 or due 
to the rare stochastic activation of an equipotent population.
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What Is Known?
•	 Vascular smooth muscle cell (VSMC) accumulation is a hallmark of 
vascular disease, including atherosclerosis.
•	 Mature VSMCs retain phenotypic plasticity, and VSMC-derived cells 
within atherosclerotic plaques can adopt, among others, a macro-
phage-like state.
What New Information Does This Article Contribute?
•	 A low percentage of VSMCs undergo extensive proliferation to gener-
ate monoclonal and oligoclonal neointima after vascular injury and in 
atherosclerosis.
•	 Individual VSMCs retain the ability to give rise to VSMC-derived cells 
within the stabilizing fibrous cap and macrophage-like cells within the 
plaque core.
•	 Cell migration independent of proliferation does not make a major con-
tribution to VSMC accumulation in disease models.
Mature VSMCs retain phenotypic plasticity, and VSMC-derived 
cells constitute the main component of injury-induced neointi-
ma and atherosclerotic plaques, but the properties of individual 
VSMCs are unknown. Here, we show that VSMC accumulation 
in disease models results from extensive proliferation of a few 
mature VSMCs. Importantly, our clonal lineage–tracing analysis 
demonstrates that individual VSMCs can give rise to plaque cells 
displaying distinct phenotypes. This study suggests that targeting 
these hyperproliferating cells, or biasing them toward a protec-
tive cap phenotype, would efficiently prevent disease progression 
while maintaining arterial structure.
Novelty and Significance
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Online Figure I: Frequency of Confetti reporter colors 
Bar chart showing the proportions of each of the Confetti colors in VSMCs directly after 
recombination (light gray), in monochromatic regions within atherosclerotic plaques (dark 
gray) and in carotid ligation-induced neointimal patches (black). All data is from high density-
labeled animals (10x 1 mg tamoxifen


















Online Figure II: Mosaic labeling of medial VSMCs
A, Longitudinal cross section of a whole mount carotid artery from a Confetti animal labeled 
at high density (10x 1 mg tamoxifen). Signals for fluorescent proteins are shown with (i) and 
without (ii) nuclear DAPI (white). Arrows point to labeled VSMCs within the medial layer, 
arrow heads point to unlabeled cells within the endothelium and adventitia. The luminal side 
is denoted as "L" and the adventitial side marked "A". Scale bar is 50 m.
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Online Figure V: Proportion of plaque cells expressing the Confetti reporter
A, Box plot quantifying the proportion of all cells (DAPI) within plaques from different regions 
of the vasculature which express the Confetti reporter (Confetti+). B, C, Box plots showing 
the proportion of cells expressing the Confetti reporter (Confetti+), which were stained for 
either aSma or Mac3 (Confetti+ Stain+) within plaques from different regions of the 
vasculature (B) or different animals (C). Red stars indicate a significant difference based on 
a two-way ANOVA, p<0.05, data from 23 plaques from 6 animals labeled at high density 













































































































 Plaque region 
Online Figure VIII: Proportion of all cells within atheroscleotic plaques and injury-
induced neointima which are VSMC-derived cells and express phenotype marker 
proteins
A-C, Box plots displaying the proportion of all plaque cells (DAPI) co-expressing the Confetti 
reporter and either aSma or Mac3 (Confetti+ Stain+) according to plaque region (A), 
individual animals (B) and vascular region (C) in high density-labeled (10x 1 mg tamoxifen) 
Rosa26-Confetti+, Myh11-CreERt2+, ApoE-/- animals after high fat diet. D, Proportion of 
total number of cells (DAPI) which co-express the Confetti reporter and either aSma or Mac3 
(Confetti+ Stain+) in carotid ligation-induced neointima from high density-labeled (10x 1 mg 
tamoxifen) Rosa26-Confetti+, Myh11-CreERt2+ animals 28 days post-surgery
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Online Figure IX: Number and distribution of Confetti colors within atherosclerotic 
plaques
A-E, Bar charts showing the proportion of plaques in high density (10x 1 mg tamoxifen, A, C-
E) and medium density (1x 1 mg tamoxifen, B) labeled animals with one, two, three or four 
colors. Bars represent the entire plaque (dark gray), the cap (light gray) or the core of the 
plaque (black). C, D, E, Data is shown for plaques in different vascular regions (C, Aortic 
Arch; D, Descending aorta; E, Carotid artery). F, Bar chart showing the proportion of 
monochromatic regions within plaques which occupy the plaque cap only (dark gray), core 
only (light gray) or both the core and cap (black). Data is shown for high density (10x 1 mg), 
low density-labeled (1x 1 mg) or all animals at the left, and stratified according to vascular 
regions on the right. Arch: aortic arch, DA: descending aorta, CA: carotid artery. 
Aortic arch  (10 mg) Descending aorta (10 mg) 
Carotid artery (10 mg) 
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